Bladder cancer SNP panel predicts susceptibility and survival
about
Human genetic variation influences vitamin C homeostasis by altering vitamin C transport and antioxidant enzyme functionTelomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysisMicrosomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human diseaseGenetic population structure analysis in New Hampshire reveals Eastern European ancestryGene-gene interaction filtering with ensemble of filtersGenetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patientsA novel survival multifactor dimensionality reduction method for detecting gene-gene interactions with application to bladder cancer prognosis.Genetic variants in telomere-maintenance genes and bladder cancer risk.HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer.Gene-Gene Interaction Analysis for the Accelerated Failure Time Model Using a Unified Model-Based Multifactor Dimensionality Reduction MethodAbsence of association of a single-nucleotide polymorphism in the TERT-CLPTM1L locus with age-related phenotypes in a large multicohort study: the HALCyon programme.A screening-testing approach for detecting gene-environment interactions using sequential penalized and unpenalized multiple logistic regressionApplication of multi-SNP approaches Bayesian LASSO and AUC-RF to detect main effects of inflammatory-gene variants associated with bladder cancer risk.Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study.An Optimization-Driven Analysis Pipeline to Uncover Biomarkers and Signaling Paths: Cervix Cancer.MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells.Gene-gene interaction analysis for the survival phenotype based on the Cox model.Survival analysis of patients with bladder cancer, life table approach.DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech populationStatistical epistasis networks reduce the computational complexity of searching three-locus genetic models.Genetic Variation in Human Vitamin C Transporter Genes in Common Complex Diseases.Identification of potential biomarkers from microarray experiments using multiple criteria optimizationIndependent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment ResponseBody mass and smoking are modifiable risk factors for recurrent bladder cancer.Regulation and roles of bicarbonate transporters in cancer.Germline genetic markers for urinary bladder cancer risk, prognosis and treatment response.Medical genetics and epigenetics of telomerase.Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs".Noninvasive approaches for detecting and monitoring bladder cancer.High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion.A 3'UTR polymorphism modulates mRNA stability of the oncogene and drug target Polo-like Kinase 1.Two genetic variants in telomerase-associated protein 1 are associated with stomach cancer risk.Knockdown of anion exchanger 2 suppressed the growth of ovarian cancer cells via mTOR/p70S6K1 signaling.Distinct cancer-specific survival in metastatic prostate cancer patients classified by a panel of single nucleotide polymorphisms of cancer-associated genes.A high frequency of MSH6 G268A polymorphism and survival association in glioblastoma.Polymorphisms in matrix metalloproteinases 2, 3, and 8 increase recurrence and mortality risk by regulating enzyme activity in gastric adenocarcinoma.Classification of Bladder Cancer Patients via Penalized Linear Discriminant AnalysisMitochondrial Markers for Cancer: Relevance to Diagnosis, Therapy, and Prognosis and General Understanding of Malignant Disease Mechanisms
P2860
Q27024648-5727790A-62A0-444F-80A2-2C379CB8C430Q28265076-1AF8FFD9-C29B-4C83-84AB-5A79D576F890Q28608628-B49D2C3A-DB12-4216-80CE-695975CAEE07Q30438705-F43B69C2-B7C9-4497-8310-4D07000ECE9BQ33826883-D71FE699-EA31-423A-B1BB-4CC51837DAABQ34042341-AB458219-4C98-47CA-800F-2269CAD2B9C0Q34146248-9C1ED90D-15B3-45B3-9FBE-3A3E2F59ACEFQ34170131-AA948B71-0AA6-49ED-8418-660427E4B37AQ34320612-4AC1CD95-996D-44A7-81E5-FDBC1BA64E39Q34550546-BDEFE9E2-7B2B-4342-9336-EF58B3E9159BQ34981178-83ED043D-2D7C-4190-B766-DB44D62037FAQ34988246-BB71E429-0B04-40C5-A3F8-F28E5BFF03D9Q35082606-A8052FC0-34B6-42B0-9DC1-AD72EEBACFF6Q35944928-7372C750-8A8F-4FD0-B395-912F1FBEA4F2Q36069642-6A72F48F-7BA7-401E-BA6D-AC884C6CD020Q36215852-47E94DE4-0DE0-4869-BD64-41916F6D46DAQ36218112-2C2948D4-AF5D-4E63-8BA2-131D379A6617Q36562413-0CB4B961-F653-4AC9-A6BE-25593101FE41Q36565137-513020D6-0D35-49AE-A2E4-379519205AA4Q36655251-3E2DB727-B530-4735-9118-71335C99BAD6Q36670980-0A135DE0-FE11-4E17-9D7F-AC696461E2ACQ36804902-E9B06C2B-3925-42E9-90AE-680B0FEAFB2CQ37054113-1CFA3AD2-4C12-4FFD-AC37-B07B5A824A8FQ37625336-D760FA60-9FDF-499B-96C2-FBA9A5EF2A57Q37719006-BF6F421E-CC6F-4556-BDF5-74E6522ACDA9Q37797468-CC9FD89C-DCA0-4149-BF86-71CFE5DCC933Q37842742-DAF7E844-B4D3-43B2-A5E3-9DC4A87FBD3FQ37850339-EF224416-8E5D-4C16-81CF-7201920E83F7Q38286089-91887CFD-63C7-4DE2-8C36-363845A91976Q39215054-0B56EA99-BC30-412C-BC79-3368DD1129ABQ39599711-ECCD820B-3B24-40E3-93BB-87A2D1774EC7Q40519654-503A3E49-BB5C-42BC-A5B0-D687C204A26DQ41123353-C9897ECC-3E7D-42B2-B255-78C8510F8C47Q42152583-C18A0463-D12C-4F17-B84B-15CA21DB48F2Q43534352-5AD66864-8FC6-48A4-923C-0D8617AABD81Q47095977-9123FB30-E9FF-4202-AF2F-0C277A491060Q56894034-52404856-E63D-4A8E-B7CC-B87EECC21545Q58690234-9F135B24-7547-44AF-921B-E4766725B1E4
P2860
Bladder cancer SNP panel predicts susceptibility and survival
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bladder cancer SNP panel predicts susceptibility and survival
@en
Bladder cancer SNP panel predicts susceptibility and survival.
@nl
type
label
Bladder cancer SNP panel predicts susceptibility and survival
@en
Bladder cancer SNP panel predicts susceptibility and survival.
@nl
prefLabel
Bladder cancer SNP panel predicts susceptibility and survival
@en
Bladder cancer SNP panel predicts susceptibility and survival.
@nl
P2093
P2860
P1433
P1476
Bladder cancer SNP panel predicts susceptibility and survival
@en
P2093
Alan R Schned
Angeline S Andrew
Arthur C Sanderson
Elaine V Morlock
Karl T Kelsey
Margaret R Karagas
Rebecca A Mason
P2860
P2888
P304
P356
10.1007/S00439-009-0645-6
P577
2009-03-01T00:00:00Z